ARBUTUS BIOPHARMA CORP revenue breakdown overview

ARBUTUS BIOPHARMA CORP revenue for the last year amounted to 16.44 M EUR, the most of which — 16.44 M EUR — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 36.46 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ARBUTUS BIOPHARMA CORP 16.44 M EUR, and the year before that — 36.46 M EUR.